Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Kala Pharmaceuticals
3197
Kala Pharmaceuticals
Technology
Biotechnology
Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
Suggest edits
Founded
2009
Raised
$109.2M
Follow us
Companies in the same industry
Synthace
Ipsen
Nabriva Therapeutics
Entertech
Aravis Ventures
Amadix
Axela
CellBioMedGroup
Diffinity Genomics
Mast Therapeutics, Inc.
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$68,000,000
Venture capital (Series C) - 2016
Polaris Partners
RA Capital Management
Wellington Management
+6
$22,500,000
Venture capital (Series B) - 2014
Polaris Partners
Lux Capital
Third Rock Ventures
+3
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
Pulse 2.0
Kala Pharmaceuticals (KALA) Stock: Why The Price Increased 17.01% Today
